Expression, purification and characterization of full-length RNA-free hepatitis B core particles

Protein Expression and Purification

Volumn 54, Issue 1, 2007, Pages 30-37

  Broos, Katleen ^a   Vanlandschoot, Peter ^b   Maras, Marleen ^c   Robbens, Johan ^c   Leroux Roels, Geert ^b   Guisez, Yves ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Virus Host Interactions Unit   (Belgium)

^c Biochemistry and Toxicology   (Belgium)

Author keywords

Heparin affinity chromatography; Hepatitis B core; Hepatitis B core hybrids; RNA free

Indexed keywords

BACTERIAL RNA;

ARTICLE; BIOSYNTHESIS; BIOTECHNOLOGY; ESCHERICHIA COLI; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; ULTRASTRUCTURE; VIRUS NUCLEOCAPSID;

BIOTECHNOLOGY; ESCHERICHIA COLI; HEPATITIS B VIRUS; NUCLEOCAPSID; RNA, BACTERIAL;

ESCHERICHIA COLI; HEPATITIS B VIRUS;

EID: 34247488830     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.02.006     Document Type: Article

References (37)

1. Pumpens P., and Grens E. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. FEBS Lett. 442 1 (1999) 1-6
2. Böttcher B., Wynne S.A., and Crowther R.A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386 6 (1997) 88-91
3. Pumpens P., and Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44 (2001) 98-114
4. Milich D.R., Hughes J., Jones J., Sällberg M., and Phillips T.R. Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate. Vaccine 20 (2002) 771-788
5. Koschel M., Thomssen R., and Bruss V. Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation. J. Virol. 73 3 (1999) 2153-2160
6. Lachmann S., Meisel H., Muselmann C., Koletzki D., Gelderblom H.R., Borisova G., Kruger D.H., Pumpens P., and Ulrich R. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology 42 1 (1999) 51-56
7. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., and Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5 10 (1999) 1157-1163
8. Petit M.A., and Pillot J. HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells. J. Virol. 53 2 (1885) 543-551
9. Nassel M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 66 7 (1992) 4107-4116
10. Gallina A., Bonelli F., Zentilin L., Rindi G., Muttini M., and Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J. Virol. 63 11 (1989) 4645-4652
11. Birnbaum F., and Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J. Virol. 64 7 (1990) 3319-3330
12. Riedl P., Stober D., Oehninger C., Melber K., Reimann J., and Schirmbeck R. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J. Immunol. 168 (2002) 4951-4959
13. Zheng J., Schodel F., and Peterson D.L. The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern. J. Biol. Chem. 267 13 (1992) 9422-9429
14. Newman M., Suk F.M., Cajimat M., Chua P.K., and Shik C. Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins. J. Virol. 77 24 (2003) 12950-12960
15. Vanlandschoot P., Van Houtte F., Serruys B., and Leroux-Roels G. The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of the nucleocapsids to cell-surface-expressed heparan sulphate. J. Gen. Virol. 86 (2005) 75-84
16. Cooper A., Tal G., Lider O., and Shaul Y. Cytokine induction by hepatitis B virus capsid in macrophages is facilitated by membrane heparin sulfate and involves TLR2. J. Immunol. 175 (2005) 3165-3176
17. Cooper A., and Shaul Y. Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J. Biol. Chem. 281 (2006) 16563-16569
18. Vanlandschoot P., Van Houtte F., Ulrichts P., Tavernier J., and Leroux-Roels G. Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked. J. Gen. Virol. 86 Pt 2 (2005) 323-331
19. Nassal M. Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization. Gene 66 2 (1988) 279-294
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
21. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
22. Schaffner W., and Weissmann C. A rapid, sensitive and specific method for the determination of protein in dilute solution. Anal. Biochem. 56 (1973) 502-514
23. Palmer E.L., and Martin M.L. Electron Microscopy in Viral Diagnosis (1988), CRC Press, Boca Raton, FL pg. 77
24. Ulrich R., Nassal M., Meisel H., and Kruger D.H. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50 (1998) 141-182
25. Wingfield P.T., Stahl S.J., Williams R.W., and Steven A.C. Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly. Biochemistry 34 (1995) 4919-4932
26. Gallina A., Bonelli F., Zentilin L., Rindi G., Muttini M., and Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J. Virol. 63 (1989) 4645-4652
27. Birkett A., Lyons K., Schmidt A., Boyd D., Oliviera G.A., Siddique A., Nussenzweig R., Calvo-Calle J.M., and Nardin E. A modified hepatitis B virus core particle containing multiple epitopes of Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in Rodent and primate hosts. Infect. Immun. 70 (2002) 6860-6870
28. Liu J., and Thorp S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22 (2002) 1-25
29. Selinka H.-C., Giroglou T., Nowak T., Christensen N.D., and Sapp M. Further evidence that papillomavirus capsids exist in two distinct conformations. J. Virol. 77 (2003) 12961-12967
30. Ng M.Y.T., Tan W.S., Abdullah N., Ling T.C., and Ti Tey B. Heat treatment of unclarified Escherichia coli homogenate improved the recovery efficiency of recombinant hepatitis B core antigen. J. Virol. Methods 137 (2006) 134-139
31. Naito M., Ishii K., Nakamura Y., Kobashi M., Takada S., and Koike K. Simple method for efficient production of hepatitis virus core antigen in Escherichia coli. Res. Virol. 148 (1997) 299-305
32. Kann M., and Gerlich W.H. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J. Virol. 68 (1994) 7993-8000
33. Rolland D., Gauthier M., Dgua J.M., Fournier C., Delpech L., Watelet B., Letourneur O., Arnaud M., and Jolivet M. Purification of recombinant HBc antigen expressed in Escherichia coli and Pichia pastoris: comparison of size-exclusion chromatography and ultrafugation. J. Chromatogr. B. 753 (2001) 51-65
34. Cooper A., and Shaul Y. Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells. Biochem. Biophys. Res. Commun. 327 4 (2005) 1094-1099
35. Takamura S., Niikura M., Li T.C., Takeda N., Kusagawa S., Takebe Y., Miyamura T., and Yasutomi Y. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Ther. 11 7 (2004) 628-635
36. Touze A., and Coursaget P. In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res. 26 5 (1998) 1317-1323
37. De Filette M., Min Jou W., Birkett A., Lyons K., Schultz B., Tonkyro A., Resch S., and Fiers W. Universal influenza A vaccine: optimization of M2-based constructs. Virology 337 1 (2005) 149-161